Literature DB >> 23101638

[Pulmonary hypertension: from molecular pathophysiology to haemodynamic abnormalities].

S Duong-Quy1, S Rivière, Y Bei, C Duong-Ngo, N N Le-Dong, T Hua-Huy, A T Dinh-Xuan.   

Abstract

Pulmonary hypertension (PH) is a complex disorder resulting from many etiologies that cause disturbances of normal pulmonary haemodynamics. Recent breakthroughs have led to a better understanding of the pathophysiology of the disease. In PH, haemodynamic disturbances are closely linked to structural changes and excessive remodeling of pulmonary vessels, leading to progressive narrowing of the pulmonary vascular lumen. Imbalances between pulmonary vasoconstrictors and vasodilators on the one hand, and factors favoring cell proliferation and apoptosis on the other hand, probably account for most cases of PH. This review aims to update readers with the current knowledge on the molecular physiopathology of PH and how this can progress the therapeutic of this disorder.
Copyright © 2012 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23101638     DOI: 10.1016/j.rmr.2012.03.009

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  2 in total

1.  Protective effects of astragaloside IV against hypoxic pulmonary hypertension.

Authors:  Xiaozheng Zhang; Jun Chen; Pan Xu; Xin Tian
Journal:  Medchemcomm       Date:  2018-09-04       Impact factor: 3.597

2.  Effects of baicalin on collagen Ι and collagen ΙΙΙ expression in pulmonary arteries of rats with hypoxic pulmonary hypertension.

Authors:  Panpan Liu; Shuangquan Yan; Mayun Chen; Ali Chen; Dan Yao; Xiaomei Xu; Xueding Cai; Liangxing Wang; Xiaoying Huang
Journal:  Int J Mol Med       Date:  2015-02-25       Impact factor: 4.101

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.